The Tufts University School of Medicine is the medical school of Tufts University, a private research university in Massachusetts. It was established in 1893 and is located on the university's health sciences campus in downtown Boston.

During the past decade, Tufts University School of Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 8 clinical trials were completed, i.e. on average, 800% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tufts University School of Medicine" #1 sponsor was "Gynecologic Oncology Group" with 18 trials, followed by "Tufts University" with 6 trials sponsored, "EMD Serono" with 2 trials sponsored, "Theratechnologies" with 2 trials sponsored and "Cubist Pharmaceuticals LLC" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tufts University School of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Brown University" with 1 trials as a collaborator, "Case Western Reserve University" with 1 trials as a collaborator and "Corporacion Ecuatoriana de Biotecnologia" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Tufts University School of Medicine" are "Ovarian Cancer" (6 trials), "Primary Peritoneal Cavity Cancer" (6 trials), "Endometrial Cancer" (5 trials), "Cervical Cancer" (4 trials) and "HIV Infections" (4 trials). Many other conditions were trialed in "Tufts University School of Medicine" in a lesser frequency.

Most popular intervention types in "Tufts University School of Medicine" are "Drug" (30 trials), "Biological" (4 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (6 trials), "Placebo" (4 trials), "gemcitabine hydrochloride" (3 trials), "paclitaxel" (3 trials) and "topotecan hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Tufts University School of Medicine" are 19 trials for "Female" genders and 16 trials for "All" genders.

Currently, there are NaN active trials in "Tufts University School of Medicine". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Tufts University School of Medicine, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Tufts University School of Medicine, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".